Brand name in­halers are very good at block­ing com­pe­ti­tion, bet­ter even than neb­u­liz­ers, study finds

While just three brand-name in­halers ap­proved be­tween 1986 and 2020 now face gener­ic com­pe­ti­tion (thanks in a large part to patent thick­ets and com­pa­nies shift­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER